Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

Add To Watchlist

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Not even TV is propping it up.

View:

Post by GoBBs on Oct 14, 2020 5:36pm

Not even TV is propping it up.

What a disaster .... by the PDUFA date this could be $3

149

Comment

Comment by aspen865 on Oct 15, 2020 12:34am

This post has been removed in accordance with Community Policy

Comment by aspen865 on Oct 20, 2020 12:08am

This post has been removed in accordance with Community Policy

Comment by realstocky on Oct 20, 2020 8:42am

This post has been removed in accordance with Community Policy

Comment by GunnerG on Oct 20, 2020 9:46am

Stups, you said that a week ago when you bought your 500 shares @ $9.17. In a week you have lost 28%, a week. If you go back to that $23.79 July 30th you keep crowing about; it has lost 72%.

Comment

Comment by Steve33 on Oct 20, 2020 9:50am

It is obviously being manipulated. Down 50 cents every day with the same general volume. There is absolutely no great reason to sell at these prices and at this time. I don't like it but they manipulate it based on market trading rules. It is not illegal. That's why trading houses thrive. They make money on the way down and up. Plus they are always ahead of the curve. Once we get this ...more

166

Comment

Comment by GunnerG on Oct 20, 2020 10:09am

So when it drops in price for no apparent reason its manipulation but when it goes up for no apparent reason its because its a great company. Maybe it was manipulated up and now its going back down to where it properly valued.

153

Comment

Liminal BioSciences Inc.